Guillaume Droesch is an experienced finance professional currently serving as an Associate at General Atlantic since November 2021, focusing on Atlantic Park investments, including Cheplapharm. Prior to this role, Guillaume was an Investment Banking Analyst in the Leveraged Finance division at Bank of America from June 2020 to November 2021 and completed a summer analyst position in Generalist (M&A and LevFin) at Bank of America Merrill Lynch in 2019. Educational credentials include a BSc in Management with Finance from the University of Warwick - Warwick Business School (2017-2020) and a French Baccalaureate from Lycée Français Charles de Gaulle de Londres (2016-2017), alongside earlier education at Le Gymnase Lucie Berger - Jean Sturm from 2011 to 2016.